Filing Details

Accession Number:
0001062993-22-002544
Form Type:
13G Filing
Publication Date:
2022-02-03 19:00:00
Filed By:
Mmcap International Inc. Spc
Company:
Lisata Therapeutics Inc. (NASDAQ:LSTA)
Filing Date:
2022-02-04
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
MMCAP International Inc. SPC 0 1,714,286 0 1,714,286 1,714,286 2.79%
MM Asset Management Inc 0 1,714,286 0 1,714,286 1,714,286 2.79%
Filing

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

SCHEDULE 13G

AMENDMENT NO. 1

INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Caladrius Biosciences Inc

(Name of Issuer)


Common Stock

(Title of Class of Securities)


128058203

(CUSIP Number)


December 31, 2021

(Date of Event Which Requires Filing of This Statement)

Check the Appropriate box to designate the rule pursuant to which this schedule is filed:

 Rule 13d-1(b)

 Rule 13d-1(c)

 Rule 13d-1(d)

CUSIP No. 128058203

13G

Page 2 of 6 Pages


1

NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

 


MMCAP International Inc. SPC

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a) 
(b) 

 

          

3

SEC USE ONLY

 

          

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Cayman Islands

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

1,714,286*

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

1,714,286*

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,714,286*

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

          

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

2.79%**

12

TYPE OF REPORTING PERSON*

 

CO

FOOTNOTES 

*Consists of 1,714,286 shares of common stock issuable upon the exercise of warrants. 
**The percentages used herein are calculated based on 59,779,855 outstanding shares of common stock of the Issuer, as represented in the Issuer’s Form 10-Q filed on November 4, 2021.

CUSIP No. 128058203

13G

Page 3 of 6 Pages


1

NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS

 


MM Asset Management Inc.

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

(a) 
(b) 

 

          

3

SEC USE ONLY

 

          

4

CITIZENSHIP OR PLACE OF ORGANIZATION

 

Ontario, Canada

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH

5

SOLE VOTING POWER

 

0

6

SHARED VOTING POWER

 

1,714,286*

7

SOLE DISPOSITIVE POWER

 

0

8

SHARED DISPOSITIVE POWER

 

1,714,286*

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

1,714,286*

10

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

 

          

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

 

2.79%**

12

TYPE OF REPORTING PERSON*

 

CO

FOOTNOTES 

*Consists of 1,714,286 shares of common stock issuable upon the exercise of warrants. 
**The percentages used herein are calculated based on 59,779,855 outstanding shares of common stock of the Issuer, as represented in the Issuer’s Form 10-Q filed on November 4, 2021.

CUSIP No. 128058203

13G

Page 4 of 6 Pages

Item 1 (a). Name of Issuer:

Caladrius Biosciences Inc

Item 1 (b). Address of Issuer's Principal Executive Offices:

110 Allen Road, Second Floor, Basking Ridge, NJ, 07920

Item 2 (a). Name of Person Filing:

i) MMCAP International Inc. SPC

ii) MM Asset Management Inc.

Item 2 (b). Address of Principal Business Office or, if None, Residence:

i) c/o Mourant Governance Services (Cayman) Limited

 94 Solaris Avenue

 Camana Bay, P.O. Box 1348
 Grand Cayman, KY1-1108, Cayman Islands

ii) 161 Bay Street
 TD Canada Trust Tower Ste 2240

Toronto, ON M5J 2S1 Canada

Item 2 (c). Citizenship:

i) Cayman Islands
ii) Ontario, Canada

Item 2 (d). Title of Class of Securities:

Common Stock

Item 2 (e). CUSIP Number:

128058203

Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

 (a)  Broker or dealer registered under Section 15 of the Act;

 (b)  Bank as defined in Section 3(a)(6) of the Act;

 (c)  Insurance Company as defined in Section 3(a)(19) of the Act;

 (d)  Investment Company registered under Section 8 of the Investment Company Act;

 (e)  Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

 (f)  Employee benefit plan or endowment plan in accordance with Rule 13d-1(b)(1)(ii)(F);

 (g)  Parent holding company or control person, in accordance with Rule 13d-1(b)(1)(ii)(G);

 (h)  A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

CUSIP No. 128058203

13G

Page 5 of 6 Pages

 (i)  A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940:

 (j)  Group, in accordance with Rule 13d-1(b)(1)(ii)(j).

  If this statement is filed pursuant to Rule 13d-1(c), check this box.

Item 4. Ownership.

 Provide the following information regarding the aggregate number and percentage of the class of securities identified in Item 1.

 (a) Amount beneficially owned: 1,714,286*

 (b) Percent of class:  2.79%**

 (c) Number of shares as to which such person has:

 (i) Sole power to vote or to direct the vote:  0

 (ii) Shared power to vote or to direct the vote:  1,714,286*

 (iii) Sole power to dispose or to direct the disposition of:  0

 (iv) Shared power to dispose or to direct the disposition of: 1,714,286*

*Consists of 1,714,286 shares of common stock issuable upon the exercise of warrants. 


**The percentages used herein are calculated based on 59,779,855 outstanding shares of common stock of the Issuer, as represented in the Issuer's Form 10-Q filed on November 4, 2021.

Instruction.  For computations regarding securities which represent a right to acquire an underlying security, see Rule 13d-3(d)(1).

Item 5. Ownership of Five Percent or Less of a Class.

 If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ X ].

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

 N/A

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

 N/A

Item 8. Identification and Classification of Members of the Group.

 N/A

Item 9. Notice of Dissolution of Group.

 N/A

CUSIP No. 128058203

13G

Page 6 of 6 Pages

Item 10. Certification.  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

SIGNATURE

 After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

MMCAP International Inc. SPC

 

 

Date: February 4, 2022

By: /s/ Matthew McIsaac

 

      Name: Matthew McIsaac

      Title: Director

 

 

 

 

 

 

 

 

 

MM Asset Management Inc.

 

 

Date: February 4, 2022

By: /s/ Hillel Meltz

 

      Name: Hillel Meltz

      Title: President